Updated cost-effectiveness analysis of first-line imatinib compared to interferon-alpha in patients with newly diagnosed chronic myeloid leukemia in the chronic phase using 60-month data from IRIS.
Reed, SD; Anstrom, KJ; Li, Y; Schulman, KA
Volume / Issue
Start / End Page
International Standard Serial Number (ISSN)
48th Annual Meeting of the American-Society-of-Hematology
Conference Start Date
Conference End Date